According to Technomic, 59% of customers who have tried CBD have used topicals, making it the most used CBD format, and usage is up since Q1 2020. Targeted as one of the most common ailments, pain, the new Happy PlaceTM product line includes CBD derived from 100% USA-grown hemp. The products have been scientifically formulated using state-of-the-art technology and rigorous testing procedures to ensure the highest level of safety, performance and consistency.
- Hydrating Cream: delivers 500mg of CBD, attracts and maintains moisture, soothes and protects skin and reduces inflammation.
- Healing Balm: relieves localized pain and inflammation, soothes itchy and irritated skin, and promotes healing with its 500mg of CBD.
- Roll-On: conveniently sized roll-on provides cooling sensation and eases pain and relaxes muscles.
- Muscle & Joint Patch: this hypoallergenic patch soothes tense and sore muscles for up to 72 hours.
“Retailers are seeking topical remedies to help their consumers with day-to-day ailments yet still want products at a great value,” said LeafLine Wellness Chief Revenue Officer Sarah Lynch. “Happy PlaceTM is committed to creating high-quality, safe and effective CBD products, while still answering our retailers’ needs to offer products in a small footprint merchandiser and sell at reasonable prices.”
The Happy Place™ Topicals products will be ready for retail outlets March 15, 2021.
ABOUT HAPPY PLACE:
Happy Place, operating under LeafLine Wellness, is engaged in the acquisition and production of hemp-derived CBD consumer products focusing on bringing GMP certified and third-party lab test products to the convenience store industry. The company’s passion is to continue to expand the CBD market through innovation, education and product quality.
LeafLine Industries owns and operates multiple companies including its two largest subsidiaries: LeafLine Labs and LeafLine Wellness. LeafLine Labs is the preferred medical cannabis licensee in the state of Minnesota using controlled-environment agriculture to cultivate cannabis for extract-based medicine to distribute through patient care centers across the state of Minnesota.